Abstract
Nuclear genome instability is known to play an important role in the origin of some human cancers. However, eukaryotic cells also have cytoplasmic genomes that are compartimentalised in the mitochondria. Mitochondria (mt) are essential for the regulation of several aspects of cell biology such as energy production, maintenance of redox status, molecular metabolism, calcium signalling and apoptosis. Oxidative stress causes significant mtDNA damage, which is thought to increase the risk of a growing number of degenerative diseases. MtDNA is highly suscepectable to mutations and contains fewer repair mechanisms than nuclear DNA, thus it may contribute to aging and be associated with the initial stages of carcinogenesis. Mitochondrial dysfunction might explain the dose-limiting toxicity of various therapeutic agents such as the nucleoside analogues used to combat HIV and hepatitis B viruses. The mitochondrial genome may represent a potential target for the development of cancer therapy. The role of mt-genomes in human diseases and in particular, in malignancy is still not fully understood. In this review, we focus on mitochondrial genome aberrations such as point mutations, instability of mono- or dinucleotide repeat, long deletions and change of the mtDNA copy number. The potential role played by mitochondria and mtDNA aberrations in malignancy, and the potential clinical use of the mtDNA markers are discussed.
Keywords: Mitochondrial Genome, dinucleotide, malignancy, mtDNA
Current Genomics
Title: Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Volume: 5 Issue: 4
Author(s): Raphael Saffroy, Franck Chiappini, Brigitte Debuire and Antoinette Lemoine
Affiliation:
Keywords: Mitochondrial Genome, dinucleotide, malignancy, mtDNA
Abstract: Nuclear genome instability is known to play an important role in the origin of some human cancers. However, eukaryotic cells also have cytoplasmic genomes that are compartimentalised in the mitochondria. Mitochondria (mt) are essential for the regulation of several aspects of cell biology such as energy production, maintenance of redox status, molecular metabolism, calcium signalling and apoptosis. Oxidative stress causes significant mtDNA damage, which is thought to increase the risk of a growing number of degenerative diseases. MtDNA is highly suscepectable to mutations and contains fewer repair mechanisms than nuclear DNA, thus it may contribute to aging and be associated with the initial stages of carcinogenesis. Mitochondrial dysfunction might explain the dose-limiting toxicity of various therapeutic agents such as the nucleoside analogues used to combat HIV and hepatitis B viruses. The mitochondrial genome may represent a potential target for the development of cancer therapy. The role of mt-genomes in human diseases and in particular, in malignancy is still not fully understood. In this review, we focus on mitochondrial genome aberrations such as point mutations, instability of mono- or dinucleotide repeat, long deletions and change of the mtDNA copy number. The potential role played by mitochondria and mtDNA aberrations in malignancy, and the potential clinical use of the mtDNA markers are discussed.
Export Options
About this article
Cite this article as:
Saffroy Raphael, Chiappini Franck, Debuire Brigitte and Lemoine Antoinette, Emerging Concepts in the Analysis of Mitochondrial Genome Instability, Current Genomics 2004; 5 (4) . https://dx.doi.org/10.2174/1389202043349228
DOI https://dx.doi.org/10.2174/1389202043349228 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis
Current Drug Targets - Inflammation & Allergy Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases
Current Diabetes Reviews The Therapeutic Potential of Hepatocyte Growth Factor for Myocardial Infarction and Heart Failure
Current Pharmaceutical Design Multiple Sclerosis: Pathogenesis and Treatment
Current Neuropharmacology Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Sterol 14α-Demethylase from Trypanosomatidae Parasites as a Promising Target for Designing New Antiparasitic Agents
Current Topics in Medicinal Chemistry Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets
Current Pharmaceutical Design Chromium-Picolinate Therapy in Diabetes Care: Molecular and Subcellular Profiling Revealed a Necessity for Individual Outcome Prediction, Personalised Treatment Algorithms & New Guidelines
Infectious Disorders - Drug Targets Application of G-CSF in Congestive Heart Failure Treatment
Current Cardiology Reviews In Vivo Imaging of Apoptosis in Cancer: Potentials and Drawbacks of Molecular Probes
Current Molecular Imaging (Discontinued) Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research
Current Medicinal Chemistry Expression and Functions of Heat Shock Proteins in the Normal and Pathological Mammalian Eye
Current Molecular Medicine Predictors of Left Ventricular Ejection Fraction Improvement after Radiofrequency Catheter Ablation in Patients with PVC-Induced Cardiomyopathy: A Systematic Review
Current Cardiology Reviews Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews